Theriva Biologics
TOVX
TOVX
20 hedge funds and large institutions have $479K invested in Theriva Biologics in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7.41K | |
| 2 | +$369 | |
| 3 | +$169 | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$136 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$11 |
Top Sellers
| 1 | -$55K | |
| 2 | -$31K | |
| 3 | -$18.4K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$18K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16K |